TREATING COCAINE-USING METHADONE PATIENTS: PREDICTORS OF OUTCOMES IN A PSYCHOSOCIAL CLINICAL TRIAL
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Бусад зохиолчид: | |
| Формат: | Ном |
| Хэл сонгох: | испани англи |
| Нөхцлүүд: | |
| Онлайн хандалт: | Path |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс: TREATING COCAINE-USING METHADONE PATIENTS: PREDICTORS OF OUTCOMES IN A PSYCHOSOCIAL CLINICAL TRIAL
- USEFUL PREDICTORS OF OUTCOME IN METHADONE-TREATED PATIENTS: RESULTS FROM A CONTROLLED CLINICAL TRIAL WITH THREE DOSES OF METHADONE.
- COST EFFECTIVENESS OF DISULFIRAM: TREATING COCAINE USE IN METHADONE-MAINTAINED PATIENTS
- CLINICAL EFFICACY OF GABAPENTIN VERSUS TIAGABINE FOR REDUCING COCAINE USE AMONG COCAINE DEPENDENT METHADONE TREATED PATIENTS
- TIAGABINE INCREASES COCAINE-FREE URINES IN COCAINE-DEPENDENT METHADONE-TREATED PATIENTS. RESULTS OF A RANDOMIZED PILOT STUDY
- DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE
- KETOCONAZOLE INCREASES COCAINE AND OPIOID USE IN METHADONE MAINTAINED PATIENTS